Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 243

1.

Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG.

Fajardo RD, van den Heuvel-Eibrink MM, van Tinteren H, Spreafico F, Acha T, Bergeron C, de Camargo B, Oldenburger F, Rübe C, Oue T, Vokuhl C, de Krijger RR, Vujanic G, Sebire N, Coulomb-L'Hermine A, Collini P, Gandola L, Pritchard-Jones K, Graf N, Janssens GO, van Grotel M.

Pediatr Blood Cancer. 2019 Oct 18:e28039. doi: 10.1002/pbc.28039. [Epub ahead of print]

PMID:
31625685
2.

Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.

Hol JA, Lopez-Yurda MI, Van Tinteren H, Van Grotel M, Godzinski J, Vujanic G, Oldenburger F, De Camargo B, Ramírez-Villar GL, Bergeron C, Pritchard-Jones K, Graf N, Van den Heuvel-Eibrink MM.

PLoS One. 2019 Aug 19;14(8):e0221373. doi: 10.1371/journal.pone.0221373. eCollection 2019.

3.

Highlights from the 13th African Continental Meeting of the International Society of Paediatric Oncology (SIOP), 6-9 March 2019, Cairo, Egypt.

Khalek ER, Afungchwi GM, Beltagy ME, Mariam N, Zaki H, Israels T, Molyneux E, Howard SC, Patte C, Schoeman J, Ladas E, Zaghloul MS, ElDeen YS, Ahmed S, Kamal S, Bouffet E, Pritchard-Jones K, Hessissen L.

Ecancermedicalscience. 2019 May 28;13:932. doi: 10.3332/ecancer.2019.932. eCollection 2019.

4.

Evaluation of needle biopsy as a potential risk factor for local recurrence of Wilms tumour in the SIOP WT 2001 trial.

Irtan S, Van Tinteren H, Graf N, van den Heuvel-Eibrink MM, Heij H, Bergeron C, de Camargo B, Acha T, Spreafico F, Vujanic G, Powis M, Okoye B, Wilde J, Godzinski J, Pritchard-Jones K.

Eur J Cancer. 2019 Jul;116:13-20. doi: 10.1016/j.ejca.2019.04.027. Epub 2019 Jun 1.

PMID:
31163337
5.

The European study on centralisation of childhood cancer treatment.

Gatta G, Botta L, Comber H, Dimitrova N, Leinonen MK, Pritchard-Jones K, Siesling S, Trama A, Van Eycken L, van der Zwan JM, Visser O, Zagar T, Capocaccia R.

Eur J Cancer. 2019 Jul;115:120-127. doi: 10.1016/j.ejca.2019.04.024. Epub 2019 May 24.

PMID:
31132742
6.

Publisher Correction: The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.

Vujanić GM, Gessler M, Ooms AHAG, Collini P, Coulomb-l'Hermine A, D'Hooghe E, de Krijger RR, Perotti D, Pritchard-Jones K, Vokuhl C, van den Heuvel-Eibrink MM, Graf N; International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG).

Nat Rev Urol. 2019 Sep;16(9):563. doi: 10.1038/s41585-019-0191-5.

PMID:
31043716
7.

Reply to the Letter to the Editor: Renal tumors in children older than 10 years-Should we be doing upfront nephrectomy?

Jackson TJ, Powis M, Vujanic GM, Pritchard-Jones K.

Pediatr Blood Cancer. 2019 Jul;66(7):e27760. doi: 10.1002/pbc.27760. Epub 2019 Apr 15. No abstract available.

PMID:
30989781
8.

Comment on: "Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelines".

Jackson TJ, Vujanic GM, Pritchard-Jones K.

Pediatr Blood Cancer. 2019 Jul;66(7):e27746. doi: 10.1002/pbc.27746. Epub 2019 Apr 2. No abstract available.

PMID:
30941850
9.

WARNING: G-401 and SK-NEP-1 cell lines are not Wilms tumor cell lines.

Pritchard-Jones K, Perotti D.

Pediatr Blood Cancer. 2019 Jul;66(7):e27741. doi: 10.1002/pbc.27741. Epub 2019 Mar 29. No abstract available.

PMID:
30924592
10.

Science and health for all children with cancer.

Lam CG, Howard SC, Bouffet E, Pritchard-Jones K.

Science. 2019 Mar 15;363(6432):1182-1186. doi: 10.1126/science.aaw4892. Review.

PMID:
30872518
11.

Stage at diagnosis for childhood solid cancers in Australia: A population-based study.

Youlden DR, Frazier AL, Gupta S, Pritchard-Jones K, Kirby ML, Baade PD, Green AC, Valery PC, Aitken JF.

Cancer Epidemiol. 2019 Apr;59:208-214. doi: 10.1016/j.canep.2019.02.013. Epub 2019 Mar 1.

12.

Outcomes of non-anaplastic stage III and 'inoperable' Wilms tumour treated in the UKW3 trial.

Irtan S, Messahel B, Moroz V, Taylor RE, Grundy R, Kelsey A, Vujanic G, Pritchard-Jones K; Renal Tumours Committee of the Children's Cancer and Leukaemia Group (CCLG).

Radiother Oncol. 2019 Feb;131:1-7. doi: 10.1016/j.radonc.2018.10.026. Epub 2018 Dec 15.

PMID:
30773174
13.

The diagnostic accuracy and clinical utility of pediatric renal tumor biopsy: Report of the UK experience in the SIOP UK WT 2001 trial.

Jackson TJ, Williams RD, Brok J, Chowdhury T, Ronghe M, Powis M, Pritchard-Jones K, Vujanić GM; Children's Cancer and Leukaemia Group (CCLG) Renal Tumours Group.

Pediatr Blood Cancer. 2019 Jun;66(6):e27627. doi: 10.1002/pbc.27627. Epub 2019 Feb 13.

14.

The genetic changes of Wilms tumour.

Treger TD, Chowdhury T, Pritchard-Jones K, Behjati S.

Nat Rev Nephrol. 2019 Apr;15(4):240-251. doi: 10.1038/s41581-019-0112-0. Review.

PMID:
30705419
15.

Pharmacotherapeutic Management of Wilms Tumor: An Update.

Oostveen RM, Pritchard-Jones K.

Paediatr Drugs. 2019 Feb;21(1):1-13. doi: 10.1007/s40272-018-0323-z. Review.

PMID:
30604241
16.

The UMBRELLA SIOP-RTSG 2016 Wilms tumour pathology and molecular biology protocol.

Vujanić GM, Gessler M, Ooms AHAG, Collini P, Coulomb-l'Hermine A, D'Hooghe E, de Krijger RR, Perotti D, Pritchard-Jones K, Vokuhl C, van den Heuvel-Eibrink MM, Graf N; International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG).

Nat Rev Urol. 2018 Nov;15(11):693-701. doi: 10.1038/s41585-018-0100-3. Erratum in: Nat Rev Urol. 2019 Sep;16(9):563.

PMID:
30310143
17.

Follow-up surveillance of Wilm's tumour - Authors' reply.

Brok J, Pritchard-Jones K, Spreafico F.

Lancet Oncol. 2018 Oct;19(10):e503. doi: 10.1016/S1470-2045(18)30691-0. Epub 2018 Oct 1. No abstract available.

PMID:
30303116
18.

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors.

Treger TD, Chagtai T, Butcher R, Cresswell GD, Al-Saadi R, Brok J, Williams RD, Roberts C, Luscombe NM, Pritchard Jones K, Mifsud W.

Transl Oncol. 2018 Dec;11(6):1301-1306. doi: 10.1016/j.tranon.2018.08.006. Epub 2018 Aug 29.

19.

Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.

Brok J, Lopez-Yurda M, Tinteren HV, Treger TD, Furtwängler R, Graf N, Bergeron C, van den Heuvel-Eibrink MM, Pritchard-Jones K, Olsen ØE, de Camargo B, Verschuur A, Spreafico F.

Lancet Oncol. 2018 Aug;19(8):1072-1081. doi: 10.1016/S1470-2045(18)30293-6. Epub 2018 Jun 27.

PMID:
29960848
20.

The Care and Outcomes of Older Persons with Lung Cancer in England and the United States, 2008-2012.

Andreano A, Peake MD, Janes SM, Valsecchi MG, Pritchard-Jones K, Hoag JR, Gross CP.

J Thorac Oncol. 2018 Jul;13(7):904-914. doi: 10.1016/j.jtho.2018.04.022. Epub 2018 May 1.

21.

Evaluation of boost irradiation in patients with intermediate-risk stage III Wilms tumour with positive lymph nodes only: Results from the SIOP-WT-2001 Registry.

Dávila Fajardo R, Oldenburger E, Rübe C, López-Yurda M, Pritchard-Jones K, Bergeron C, Graf N, van Grotel M, van Tinteren H, Saunders D, van den Heuvel-Eibrink MM, Janssens GO, Oldenburger F.

Pediatr Blood Cancer. 2018 Aug;65(8):e27085. doi: 10.1002/pbc.27085. Epub 2018 Apr 25.

PMID:
29693799
22.

Evidence-based data and rare cancers: The need for a new methodological approach in research and investigation.

Mathoulin-Pélissier S, Pritchard-Jones K.

Eur J Surg Oncol. 2019 Jan;45(1):22-30. doi: 10.1016/j.ejso.2018.02.015. Epub 2018 Mar 2.

PMID:
29526369
23.

Discrete-choice experiment to analyse preferences for centralizing specialist cancer surgery services.

Vallejo-Torres L, Melnychuk M, Vindrola-Padros C, Aitchison M, Clarke CS, Fulop NJ, Hines J, Levermore C, Maddineni SB, Perry C, Pritchard-Jones K, Ramsay AIG, Shackley DC, Morris S.

Br J Surg. 2018 Apr;105(5):587-596. doi: 10.1002/bjs.10761. Epub 2018 Mar 7.

24.

Centralising specialist cancer surgery services in England: survey of factors that matter to patients and carers and health professionals.

Melnychuk M, Vindrola-Padros C, Aitchison M, Clarke CS, Fulop NJ, Levermore C, Maddineni SB, Moore CM, Mughal MM, Perry C, Pritchard-Jones K, Ramsay AIG, Shackley D, Vickers J, Morris S.

BMC Cancer. 2018 Feb 27;18(1):226. doi: 10.1186/s12885-018-4137-8.

25.

Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocol.

Gooskens SL, Graf N, Furtwängler R, Spreafico F, Bergeron C, Ramírez-Villar GL, Godzinski J, Rübe C, Janssens GO, Vujanic GM, Leuschner I, Coulomb-L'Hermine A, Smets AM, de Camargo B, Stoneham S, van Tinteren H, Pritchard-Jones K, van den Heuvel-Eibrink MM; International Society of Paediatric Oncology–Renal Tumour Study Group (SIOP–RTSG).

Nat Rev Urol. 2018 May;15(5):309-319. doi: 10.1038/nrurol.2018.14. Epub 2018 Feb 27. Review.

PMID:
29485128
26.

Childhood cancer incidence and survival in Japan and England: A population-based study (1993-2010).

Nakata K, Ito Y, Magadi W, Bonaventure A, Stiller CA, Katanoda K, Matsuda T, Miyashiro I, Pritchard-Jones K, Rachet B.

Cancer Sci. 2018 Feb;109(2):422-434. doi: 10.1111/cas.13457. Epub 2017 Dec 26.

27.

Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.

van den Heuvel-Eibrink MM, Hol JA, Pritchard-Jones K, van Tinteren H, Furtwängler R, Verschuur AC, Vujanic GM, Leuschner I, Brok J, Rübe C, Smets AM, Janssens GO, Godzinski J, Ramírez-Villar GL, de Camargo B, Segers H, Collini P, Gessler M, Bergeron C, Spreafico F, Graf N; International Society of Paediatric Oncology — Renal Tumour Study Group (SIOP–RTSG).

Nat Rev Urol. 2017 Dec;14(12):743-752. doi: 10.1038/nrurol.2017.163. Epub 2017 Oct 31. Review.

PMID:
29089605
28.

Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.

Hol JA, van den Heuvel-Eibrink MM, Graf N, Pritchard-Jones K, Brok J, van Tinteren H, Howell L, Verschuur A, Bergeron C, Kager L, Catania S, Spreafico F, Mavinkurve-Groothuis AMC.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26849. Epub 2017 Oct 27.

PMID:
29077255
29.

Paediatrics: Integrating genomics to dig deeper into Wilms tumour biology.

Mifsud W, Pritchard-Jones K.

Nat Rev Urol. 2017 Dec;14(12):703-704. doi: 10.1038/nrurol.2017.178. Epub 2017 Oct 25. No abstract available.

PMID:
29068437
30.

Bilateral Wilms tumour: a review of clinical and molecular features.

Charlton J, Irtan S, Bergeron C, Pritchard-Jones K.

Expert Rev Mol Med. 2017 Jul 18;19:e8. doi: 10.1017/erm.2017.8. Review.

31.

Review of phase I and II trials for Wilms' tumour - Can we optimise the search for novel agents?

Brok J, Pritchard-Jones K, Geller JI, Spreafico F.

Eur J Cancer. 2017 Jul;79:205-213. doi: 10.1016/j.ejca.2017.04.005. Epub 2017 May 15. Review.

PMID:
28521171
32.

Nephrogenic rests in Wilms tumors treated with preoperative chemotherapy: The UK SIOP Wilms Tumor 2001 Trial experience.

Vujanić GM, Apps JR, Moroz V, Ceroni F, Williams RD, Sebire NJ, Pritchard-Jones K.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26547. Epub 2017 Apr 6.

PMID:
28383760
33.

Congenital mesoblastic nephroma 50 years after its recognition: A narrative review.

Gooskens SL, Houwing ME, Vujanic GM, Dome JS, Diertens T, Coulomb-l'Herminé A, Godzinski J, Pritchard-Jones K, Graf N, van den Heuvel-Eibrink MM.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26437. Epub 2017 Jan 26. Review.

PMID:
28124468
34.

Biology and treatment of renal tumours in childhood.

Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K.

Eur J Cancer. 2016 Oct 28;68:179-195. doi: 10.1016/j.ejca.2016.09.005. [Epub ahead of print] Review.

35.

Wilms tumor: "State-of-the-art" update, 2016.

Irtan S, Ehrlich PF, Pritchard-Jones K.

Semin Pediatr Surg. 2016 Oct;25(5):250-256. doi: 10.1053/j.sempedsurg.2016.09.003. Epub 2016 Sep 4. Review.

PMID:
27955727
36.

Role of CD56 in Normal Kidney Development and Wilms Tumorigenesis.

Yap LW, Brok J, Pritchard-Jones K.

Fetal Pediatr Pathol. 2017 Feb;36(1):62-75. doi: 10.1080/15513815.2016.1256358. Epub 2016 Dec 9. Review.

PMID:
27935326
37.

Reorganising specialist cancer surgery for the twenty-first century: a mixed methods evaluation (RESPECT-21).

Fulop NJ, Ramsay AI, Vindrola-Padros C, Aitchison M, Boaden RJ, Brinton V, Clarke CS, Hines J, Hunter RM, Levermore C, Maddineni SB, Melnychuk M, Moore CM, Mughal MM, Perry C, Pritchard-Jones K, Shackley DC, Vickers J, Morris S.

Implement Sci. 2016 Nov 25;11(1):155.

38.

Study protocol for a randomised controlled trial of brief, habit-based, lifestyle advice for cancer survivors: exploring behavioural outcomes for the Advancing Survivorship Cancer Outcomes Trial (ASCOT).

Beeken RJ, Croker H, Heinrich M, Smith L, Williams K, Hackshaw A, Hines J, Machesney M, Krishnaswamy M, Cavanagh S, Roylance R, Hill A, Pritchard-Jones K, Wardle J, Fisher A.

BMJ Open. 2016 Nov 23;6(11):e011646. doi: 10.1136/bmjopen-2016-011646.

39.

Diagnosis of cancer as an emergency: a critical review of current evidence.

Zhou Y, Abel GA, Hamilton W, Pritchard-Jones K, Gross CP, Walter FM, Renzi C, Johnson S, McPhail S, Elliss-Brookes L, Lyratzopoulos G.

Nat Rev Clin Oncol. 2017 Jan;14(1):45-56. doi: 10.1038/nrclinonc.2016.155. Epub 2016 Oct 11. Review.

PMID:
27725680
40.

The Clinical Relevance of Age at Presentation in Nephroblastoma.

Gooskens SL, Segers H, Pritchard-Jones K, Graf N, Dome JS, van den Heuvel-Eibrink MM.

In: van den Heuvel-Eibrink MM, editor. Wilms Tumor [Internet]. Brisbane (AU): Codon Publications; 2016 Mar. Chapter 2.

41.

Gain of 1q As a Prognostic Biomarker in Wilms Tumors (WTs) Treated With Preoperative Chemotherapy in the International Society of Paediatric Oncology (SIOP) WT 2001 Trial: A SIOP Renal Tumours Biology Consortium Study.

Chagtai T, Zill C, Dainese L, Wegert J, Savola S, Popov S, Mifsud W, Vujanić G, Sebire N, Le Bouc Y, Ambros PF, Kager L, O'Sullivan MJ, Blaise A, Bergeron C, Mengelbier LH, Gisselsson D, Kool M, Tytgat GA, van den Heuvel-Eibrink MM, Graf N, van Tinteren H, Coulomb A, Gessler M, Williams RD, Pritchard-Jones K.

J Clin Oncol. 2016 Sep 10;34(26):3195-203. doi: 10.1200/JCO.2015.66.0001. Epub 2016 Jul 18. Erratum in: J Clin Oncol. 2017 Jun 20;35(18):2100.

42.

WT1 Mutation in Childhood Cancer.

Charlton J, Pritchard-Jones K.

Methods Mol Biol. 2016;1467:1-14. doi: 10.1007/978-1-4939-4023-3_1.

PMID:
27417955
43.

Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications.

Cresswell GD, Apps JR, Chagtai T, Mifsud B, Bentley CC, Maschietto M, Popov SD, Weeks ME, Olsen ØE, Sebire NJ, Pritchard-Jones K, Luscombe NM, Williams RD, Mifsud W.

EBioMedicine. 2016 Jul;9:120-129. doi: 10.1016/j.ebiom.2016.05.029. Epub 2016 May 27.

44.

Ethical issues of clinical trials in paediatric oncology from 2003 to 2013: a systematic review.

Dupont JC, Pritchard-Jones K, Doz F.

Lancet Oncol. 2016 May;17(5):e187-97. doi: 10.1016/S1470-2045(16)00142-X. Epub 2016 Apr 27. Review.

PMID:
27301046
45.

Paediatric cancer stage in population-based cancer registries: the Toronto consensus principles and guidelines.

Gupta S, Aitken JF, Bartels U, Brierley J, Dolendo M, Friedrich P, Fuentes-Alabi S, Garrido CP, Gatta G, Gospodarowicz M, Gross T, Howard SC, Molyneux E, Moreno F, Pole JD, Pritchard-Jones K, Ramirez O, Ries LAG, Rodriguez-Galindo C, Shin HY, Steliarova-Foucher E, Sung L, Supriyadi E, Swaminathan R, Torode J, Vora T, Kutluk T, Frazier AL.

Lancet Oncol. 2016 Apr;17(4):e163-e172. doi: 10.1016/S1470-2045(15)00539-2. Epub 2016 Mar 29. Review.

PMID:
27300676
46.

European Survey on Standards of Care in paediatric oncology centres.

Kowalczyk JR, Samardakiewicz M, Pritchard-Jones K, Ladenstein R, Essiaf S, Fitzgerald E, Petrarulo G, Vassal G.

Eur J Cancer. 2016 Jul;61:11-9. doi: 10.1016/j.ejca.2016.03.073. Epub 2016 Apr 28.

PMID:
27131152
47.

Risk of Adverse Health and Social Outcomes Up to 50 Years After Wilms Tumor: The British Childhood Cancer Survivor Study.

Wong KF, Reulen RC, Winter DL, Guha J, Fidler MM, Kelly J, Lancashire ER, Pritchard-Jones K, Jenkinson HC, Sugden E, Levitt G, Frobisher C, Hawkins MM.

J Clin Oncol. 2016 May 20;34(15):1772-9. doi: 10.1200/JCO.2015.64.4344. Epub 2016 Mar 28.

PMID:
27022116
48.

Evidence for a delay in diagnosis of Wilms' tumour in the UK compared with Germany: implications for primary care for children.

Pritchard-Jones K, Graf N, van Tinteren H, Craft A.

Arch Dis Child. 2016 May;101(5):417-20. doi: 10.1136/archdischild-2015-309212. Epub 2016 Mar 6.

49.

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens.

Veal GJ, Errington J, Sastry J, Chisholm J, Brock P, Morgenstern D, Pritchard-Jones K, Chowdhury T.

Cancer Chemother Pharmacol. 2016 Apr;77(4):685-92. doi: 10.1007/s00280-016-2975-0. Epub 2016 Feb 13.

50.

The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney.

Gooskens SL, Kenny C, Lazaro A, O'Meara E, van Tinteren H, Spreafico F, Vujanic G, Leuschner I, Coulomb-L'Herminé A, Perotti D, de Camargo B, Bergeron C, Acha García T, Tanaka M, Pieters R, Pritchard-Jones K, Graf N, van den Heuvel-Eibrink MM, O'Sullivan MJ.

Genes Chromosomes Cancer. 2016 Feb;55(2):143-7. doi: 10.1002/gcc.22320. Epub 2015 Nov 6.

PMID:
26542179

Supplemental Content

Loading ...
Support Center